Case Study

MOLECULAR MEDICINE COMPANY

MOLECULAR MEDICINE COMPANY

Pages 2 Pages

A clinical-stage precision medicine company faced challenges with its traditional, paper-based computer software validation (CSV) approach, hindering its ability to ensure GxP compliance across its digital ecosystem, including Veeva and DocuSign. To streamline processes and maintain compliance with increasing software releases, the company sought a more efficient validation method. Integrating Veeva Vault with DocuSign, enables streamlined document workflows, e-signatures, and compliance with regulations like 21 CFR Part 11, all within a single platform. This integration helps ensure data integrity, reduces manual processes, and accelerates the medicine discovery process.

Join for free to read